Munich
Germany
19
2026-04-30
The entities that hold a legal rights for patent applications filed by inventor Klinger Matthias:
Matthias Klinger from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
#2 | 2025-10-30BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION
#3 | 2025-09-11HETEROMULTIMER BINDING DLL3 AND CD3
#4 | 2025-05-22CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
#5 | 2024-06-27MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SELECTIVITY
#6 | 2023-12-21POLYPEPTIDE CONSTRUCTS BINDING TO CD3
#7 | 2022-12-22MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES
#8 | 2022-03-24Means and Methods for Treating Tumorous Diseases
#9 | 2022-02-10Cross-species-specific single domain bispecific single chain antibody
#10 | 2020-11-19CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
#11 | 2020-03-26CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#12 | 2019-06-06CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
#13 | 2017-11-16Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
#14 | 2017-09-28BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION
#15 | 2016-06-02CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#16 | 2013-05-23Cross-species-specific PSMAxCD3 bispecific single chain antibody
#17 | 2012-02-09CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
#18 | 2011-12-01CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
#19 | 2011-11-10Cross-species-specific single domain bispecific single chain antibody
260842 ⎘